Bullous pemphigoid probably associated with pembrolizumab: a case of delayed toxicity.

MLA

Correia, Catarina, et al. “Bullous Pemphigoid Probably Associated with Pembrolizumab: A Case of Delayed Toxicity.” International Journal of Dermatology, vol. 61, no. 4, Apr. 2022, pp. e129–31. EBSCOhost, https://doi.org/10.1111/ijd.15796.

APA

Correia, C., Fernandes, S., Soares, de‐Almeida, L., & Filipe, P. (2022). Bullous pemphigoid probably associated with pembrolizumab: a case of delayed toxicity. International Journal of Dermatology, 61(4), e129–e131. https://doi.org/10.1111/ijd.15796

Chicago

Correia, Catarina, Sónia Fernandes, de‐Almeida, Luís Soares, and Paulo Filipe. 2022. “Bullous Pemphigoid Probably Associated with Pembrolizumab: A Case of Delayed Toxicity.” International Journal of Dermatology 61 (4): e129–31. doi:10.1111/ijd.15796.